Get the Stockscreener App
9.31
1.17%
-0.11
After Hours:
9.29
-0.02
-0.21%
Rxsight Inc stock is traded at $9.31, with a volume of 733.01K.
It is down -1.17% in the last 24 hours and up +26.67% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$9.42
Open:
$9.43
24h Volume:
733.01K
Relative Volume:
0.55
Market Cap:
$380.93M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-11.35
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
+4.72%
1M Performance:
+26.67%
6M Performance:
-64.29%
1Y Performance:
-82.93%
1-Day Range:
$9.10
$9.565
1-Week Range:
$8.55
$10.25
52-Week Range:
$6.32
$57.53
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
9.31 | 409.98M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-09-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-09-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-09-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-19-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
RXST Deadline: Rosen Law Firm Urges RxSight, Inc. (NASDAQ: RXST) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
Berger Montague Reminds RxSight, Inc. (NASDAQ: RXST) Investors With Substantial Losses to Inquire About a Securities Fraud Class Action by September 22, 2025 - MarketScreener
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewswire
RxSight (NASDAQ:RXST) Stock Rating Upgraded by Zacks Research - MarketBeat
Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - PR Newswire
Hopeful Week For Insiders Who Bought US$1.11m Of RxSight Stock - simplywall.st
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - Louisiana First News
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
RxSight, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before September 22, 2025 to Discuss Your RightsRXST - PR Newswire
RxSight (NASDAQ:RXST) Upgraded at Zacks Research - Defense World
RXST FRAUD NOTICE: RxSight, Inc. Hit with Securities Class - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
RXST LAWSUIT ALERT: The Gross Law Firm Notifies RxSight, - GlobeNewswire
Levi & Korsinsky Urges RxSight, Inc. (RXST) Shareholders to Act Before Lead Plaintiff Deadline September 22, 2025 - ACCESS Newswire
RXST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - Newsfile
RxSight, Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
Northern Trust Corp Buys 35,021 Shares of RxSight, Inc. $RXST - MarketBeat
RXST INVESTOR DEADLINE: RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire
Is RxSight Inc. a top pick in the sectorJuly 2025 Intraday Action & Stepwise Trade Signal Implementation - Lancaster City Council
Class Action Alert: Levi & Korsinsky Reminds RxSight, Inc. (RXST) Investors of September 22, 2025 Deadline - ACCESS Newswire
Can RxSight Inc. reach all time highs this year2025 Analyst Calls & Verified Trade Idea Suggestions - Lancaster City Council
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Business Wire
Investor Alert: Deadline Approaching to Join RxSight, Inc. (RXST) Class ActionContact Levi & Korsinsky - ACCESS Newswire
RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein - GlobeNewswire
DEADLINE APPROACHING: Berger Montague Advises RxSight, Inc. (NASDAQ - MarketScreener
RxSight, Inc. Class Action: Levi & Korsinsky Reminds - GlobeNewswire
How to contact the Daily Bulletin - FinancialContent
RXST LAWSUIT ALERT: The Gross Law Firm Notifies RxSight, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar
RXST SHAREHOLDERS: RxSight, Inc. LAL Utilization Decline - GlobeNewswire
Securities Fraud Class Action Filed Against RxSight, Inc. (RXST)Levi & Korsinsky Reminds Investors of September 22, 2025 - ACCESS Newswire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been - Bluefield Daily Telegraph
Lost Money on RxSight, Inc. (RXST)? Contact Levi & Korsinsky Before September 22, 2025 to Join Class Action - ACCESS Newswire
Faruqi & Faruqi Reminds RxSight Investors of the Pending - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - PR Newswire
Class Action Lawsuit Filed: RxSight, Inc. (RXST)Join by September 22, 2025 – Contact Levi & Korsinsky - ACCESS Newswire
RXST LAWSUIT NOTICE: Lose Money on RxSight, Inc.? Contact - GlobeNewswire
142,036 Shares in RxSight, Inc. $RXST Bought by Armistice Capital LLC - MarketBeat
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - PR Newswire
Levi & Korsinsky Notifies Shareholders of RxSight, Inc.(RXST) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Can momentum traders help lift RxSight Inc.2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
RxSight, Inc. Class Action: The Gross Law Firm Reminds - GlobeNewswire
RXST CLASS ALERT: BFA Alerts RxSight, Inc. Investors with - GlobeNewswire
Securities Fraud and Shareholder Risks at RxSight (RXST): Assessing Legal and Financial Implications - AInvest
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. LawsuitRXST - Morningstar
RxSight, Inc. (NASDAQ: RXST) Investor Alert: Deadline in Lawsuit on September 22, 2025 - openPR.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewswire
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):